Skip to main content

Endo to supply Vasostrict through Premier

Vasostrict is used in critical care, including some of the most acute cases of COVID-19.
Levy

Endo’s Par Sterile Products business will supply Vasostrict, vasopressin injection, vial presentations to healthcare providers through Premier's Premier ProRx program, helping to maintain supply continuity for a medication needed in critical care, including some of the most acute cases of COVID-19.

"We're pleased to join Premier in addressing industry drug shortages and serving as a guaranteed supplier of Vasostrict—proudly produced in our Rochester, Mich. facility," said Scott Sims, senior vice president and general manager of sterile injectables at Endo.

[Read more: Strides completes acquisition of Endo's U.S. manufacturing facility]

Sims added, "As a longstanding Premier partner, we welcome the opportunity to work with them via their Premier ProRx program to offer Vasostrict through their robust and highly reliable supply channel."

[Read more: State of the Pharmacy 2021: Executives weigh in]

 

X
This ad will auto-close in 10 seconds